Thermo Fisher Scientific TMO
Quarterly report 2024-Q3
added 11-01-2024
Country |
USA |
IPO year |
- |
Industry |
Diagnostics research |
Stock Exchange |
NYSESPB |
CEO |
Mr. Marc Casper |
Employees in the company |
75 000 |
Shares |
386 M |
Market Cap[1] |
$ 214 B |
EBITDA (LTM) |
$ 8.2 B |
P/E (LTM) |
34.4 |
P/S (LTM) |
5.12 |
EPS (LTM) |
16.22 |
Thermo Fisher Scientific is a globally leading company in the life science industry, focusing on the development and manufacturing of products and services for research, diagnostics, and drug production. The company was founded in 2006 and is headquartered in Waltham, Massachusetts.
Thermo Fisher Scientific offers a wide range of products, including laboratory equipment, reagents, consumables, software, and services. The company serves customers in the pharmaceutical and biotech, diagnostics, academic research, and government sectors.
The mission of Thermo Fisher Scientific is to help its customers make the world healthier, cleaner, and safer. The company is also committed to sustainability and aims to reduce its greenhouse gas emissions by 50% by 2030.
Thermo Fisher Scientific is known for its innovation and has received numerous awards for its products and technologies. The company has also made several acquisitions to expand its product offerings and strengthen its presence in different regions.
Overall, is a leading company in the life science industry that is committed to innovation, sustainability, and customer satisfaction. Its products and services have a positive impact on the health and well-being of people around the world.
Other stocks of industry "Diagnostics research"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.